Treatment of antineutrophil cytoplasm autoantibody-associated systemic vasculitis: initiatives of the European Community Systemic Vasculitis Clinical Trials Study Group.
The diagnosis, treatment, and monitoring of the primary systemic vasculitides associated with circulating antineutrophil cytoplasm autoantibodies (ANCA) have formed the focus of a multicenter collaborative study. Consensus has been reached on criteria for classification, clinical subgroupings by ext...
主要な著者: | Jayne, DR, Rasmussen, N |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
1997
|
類似資料
-
Remission in antineutrophil cytoplasmic antibody-associated systemic vasculitis.
著者:: Mukhtyar, C, 等
出版事項: (2006) -
Comments on: Antineutrophil cytoplasmic autoantibody associated vasculitis-Clinical profile and outcomes
著者:: Rohini Handa
出版事項: (2018-01-01) -
Ischaemic stroke as the first presentation of antineutrophilic cytoplasmic autoantibody‐associated vasculitis
著者:: John Chuan Nguyen Tran, 等
出版事項: (2022-12-01) -
Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?
著者:: Flossmann, O, 等
出版事項: (2006) -
Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis with Kidney Involvement in a Patient with AL Amyloidosis
著者:: Brendan L. Thoms, 等
出版事項: (2021-07-01)